免疫检查点 TIM-3 在瘤免疫治疗中
Shuaiya Ma1, Mengyao Zhu2, Chunhong Ma2
1The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China.
Acta biochimica et biophysica Sinica
|December 24, 2025
概括
免疫检查点抑制剂 (ICI) 在癌症治疗中表现有前途,但低的成功率需要探索新的标,如T细胞免疫球蛋白和含粘素的分子-3 (TIM-3). 准TIM-3为有效的癌症免疫治疗提供了一个新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 免疫疗法,特别是像CTLA-4和PD-1这样的免疫检查点抑制剂 (ICI),已经彻底改变了癌症治疗.
- 尽管取得了成功,但当前ICI的疗效在许多患者中是有限的.
- 需要识别和准新型免疫检查点分子以改善治疗结果.
研究的目的:
- 审查了解T细胞免疫球蛋白和含粘素分子-3 (TIM-3) 在调节免疫反应中的作用方面的进展.
- 探索向TIM-3作为癌症新型免疫治疗策略的潜力.
- 讨论将TIM-3向与其他ICI相结合的理论框架,以提高有效性.
主要方法:
- 在各种免疫细胞 (T细胞,NK细胞,巨细胞,树突细胞) 中对TIM-3功能研究的文献综述.
- 对研究TIM-3表达及其对抗瘤免疫力的影响的研究分析.
- 基于TIM-3的组合疗法的理论方法的综合.
主要成果:
- TIM-3在多种免疫细胞类型上表达,对于抗瘤反应至关重要.
- 在瘤微环境中,TIM-3作为免疫细胞功能的重要调节者.
- 临床前和新出现的临床数据表明,TIM-3是癌症免疫治疗的可行目标.
结论:
- 蒂姆-3代表了一个有希望的下一代免疫检查点目标.
- 针对TIM-3,特别是与现有的ICI结合使用,有可能克服当前免疫治疗的局限性.
- 为了推进癌症治疗,需要对TIM-3生物学和治疗策略进行进一步的研究.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


